IL10 and asthma: Furthermore, it has been reported that IL-210-activated DCs can abrogate experimental asthma (12), while several studies have recently demonstrated that LPS, which is most frequently used to stimulate DCs maturation in vitro to initiate immune responses, can also render DCs to exert immunosuppressive effects by producing sufficient IL-10 (13, 14).